Continuous glucose monitors used to be medical devices exclusively for diabetics. Now they are being worn by healthy people who want to understand how food, exercise, sleep, and stress affect their blood sugar. The market has responded with consumer-focused options that do not require a prescription.
Three devices dominate the non-diabetic CGM space: Dexcom's Stelo, the Dexcom G7, and Abbott's Lingo. Here is how they compare.
Why Non-Diabetics Are Wearing CGMs
The premise is straightforward: glucose variability -- the magnitude and frequency of blood sugar spikes and crashes -- may be a meaningful health metric even for people with normal glucose regulation. The hypothesis is that minimizing postprandial (post-meal) glucose spikes reduces inflammation, improves energy levels, and may support long-term metabolic health.
Proponents point to data showing that even "normal" glucose ranges include significant variability, and that individuals with flatter glucose curves tend to have better metabolic markers, body composition, and subjective energy.
Critics argue that in truly non-diabetic individuals, the body regulates glucose effectively, and the minor spikes observed after meals are physiologically normal and not harmful.
The truth is somewhere in between. CGM data is genuinely useful for identifying foods that spike your personal glucose response, optimizing meal timing and composition, and understanding how exercise and sleep affect blood sugar. Whether this translates to long-term health benefits for non-diabetics remains unproven.
The Devices
Dexcom Stelo
Dexcom Stelo is Dexcom's consumer-focused CGM, designed specifically for non-diabetics and available over the counter without a prescription.
Key specs:
- 15-day sensor wear time
- No prescription required
- Real-time glucose readings via smartphone app
- Glucose trend data and pattern recognition
- No alarms or alerts (by design, for non-diabetic use)
- Approximate cost: $99 per month (2 sensors)
Stelo uses Dexcom's proven sensor technology but with a consumer-friendly app interface focused on food response tracking, pattern identification, and metabolic insights rather than medical glucose management.
Dexcom G7
The G7 is Dexcom's medical-grade CGM, primarily designed for diabetics but used off-label by health optimizers. It requires a prescription.
Key specs:
- 10-day sensor wear time (plus 12-hour warm-up grace period)
- Prescription required
- Real-time glucose with customizable alerts
- Integration with insulin pumps and medical devices
- Share data with up to 10 followers
- Approximate cost: $75-150 per month depending on insurance
The G7 is more clinically capable than Stelo, with configurable high/low glucose alerts and tighter accuracy specifications. For non-diabetic use, the medical alerts are unnecessary but the sensor accuracy is appealing.
Abbott Lingo
Abbott Lingo is Abbott's entry into the consumer wellness CGM market, built on their FreeStyle Libre sensor technology.
Key specs:
- 14-day sensor wear time
- No prescription required
- Real-time glucose via smartphone app
- Focus on metabolic health insights and coaching
- Energy Score and food logging features
- Approximate cost: $49-99 per month depending on plan
Lingo positions itself as a metabolic health coaching platform rather than just a glucose monitor. The app provides more contextual guidance about what your glucose data means and how to improve it.
If you are trying a CGM for the first time and do not have a specific medical need, start with Stelo or Lingo. They are designed for the non-diabetic consumer experience. The G7's medical features add complexity without benefit for most health optimizers.
Accuracy Comparison
All three devices use subcutaneous sensors that measure glucose in interstitial fluid, which lags behind blood glucose by approximately 5-15 minutes.
Dexcom G7: MARD (Mean Absolute Relative Difference) of approximately 8.2%, the tightest accuracy specification of the three. This is medical-grade accuracy.
Dexcom Stelo: Uses similar sensor technology to the G7. Dexcom has not published a separate MARD for Stelo, but accuracy is expected to be comparable or slightly less precise than the G7.
Abbott Lingo: Based on FreeStyle Libre 3 technology with a MARD of approximately 7.9% (Libre 3 specification). Individual performance can vary.
For non-diabetic use, all three are accurate enough to identify glucose trends and food responses. The differences in MARD are clinically relevant for insulin dosing in diabetics but largely irrelevant for wellness tracking.
App and Insights Comparison
| Feature | Stelo | G7 | Lingo |
|---|---|---|---|
| Real-time glucose | Yes | Yes | Yes |
| Food response tracking | Yes | Manual only | Yes |
| Metabolic coaching | Basic | None | Detailed |
| Customizable alerts | No | Yes | No |
| Medical integration | No | Yes | No |
| Data export | Yes | Yes | Yes |
| Prescription required | No | Yes | No |
Stelo focuses on clean data visualization with moderate coaching.
G7 provides the raw data with medical-grade precision but minimal wellness coaching. You need to bring your own interpretation framework.
Lingo offers the most guided experience with an Energy Score, food logging integration, and contextual insights about your glucose patterns.
What You Will Actually Learn
Most non-diabetics who wear a CGM for 2-4 weeks learn the same core lessons:
- Specific foods spike you more than expected. White rice, certain fruits, and foods you thought were "healthy" may produce large glucose spikes in your body specifically.
- Food order and combination matter. Eating protein and fiber before carbohydrates significantly blunts the glucose response.
- Post-meal walking works. A 10-15 minute walk after eating reduces glucose spikes by 30-50% in most people.
- Sleep deprivation wrecks glucose regulation. One night of poor sleep can increase glucose variability by 20-40% the following day.
- Exercise timing affects blood sugar. Morning exercise may improve glucose regulation for the rest of the day.
The biggest risk of CGM use in non-diabetics is developing an unhealthy relationship with glucose data. Normal post-meal glucose rises (up to 140 mg/dL) are physiological, not pathological. Obsessing over keeping glucose perfectly flat can lead to unnecessary food restriction and anxiety.
How Long Should You Wear One
For most non-diabetics, 2-4 weeks of CGM data provides the majority of actionable insights. After that, you have identified your personal food responses and the behavioral strategies (meal composition, walking, sleep) that work for you.
Continuous long-term wear is rarely necessary unless you are running specific experiments or managing a pre-diabetic condition. The cost-to-insight ratio drops significantly after the initial learning period.
Pros
- +Identifies personal glucose responses to specific foods
- +Motivates post-meal movement and better meal composition
- +Reveals impact of sleep and stress on metabolic regulation
- +Over-the-counter options now available without prescription
- +Data is genuinely useful for 2-4 weeks of experimentation
Cons
- -Ongoing cost of $50-150/month for sensor replacements
- -Long-term benefit for non-diabetics is not proven
- -Can promote unhealthy food anxiety and orthorexic tendencies
- -Normal post-meal glucose rises may be over-pathologized
- -Diminishing returns after initial 2-4 week learning period
Be the first to try Prova
We're building an app to track whether glucose monitoring and metabolic tracking actually works. Join the waitlist.
Frequently Asked Questions
This article is for informational purposes only. Prova has no affiliation with Dexcom or Abbott. Product specifications, pricing, and availability may change. Consult official sources and a healthcare provider for medical guidance on glucose monitoring.